Julie Lorent Selected Research

1- (2- (1- (2- aminopyrimidin- 4- yl)- 2- ((2- methoxyethyl)amino)- 1H- 1,3- benzodiazol- 6- yl)ethynyl)cyclohexan- 1- ol

12/2015

p21-activated kinase group II small compound inhibitor GNE-2861 perturbs estrogen receptor alpha signaling and restores tamoxifen-sensitivity in breast cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julie Lorent Research Topics

Disease

7	Neoplasms (Cancer) 01/2022 - 01/2012
2	Infections 01/2020 - 01/2018
2	Inflammation (Inflammations) 01/2020 - 01/2018
2	Breast Neoplasms (Breast Cancer) 01/2018 - 12/2015
1	Melanoma (Melanoma, Malignant) 01/2022
1	Parasitic Diseases (Parasitic Disease) 01/2018
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2016

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2018
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2020
2	Estrogen Receptor alphaIBA 12/2019 - 12/2015
1	ProteomeIBA 12/2019
1	Hormones (Hormone)IBA 12/2019
1	CytokinesIBA 01/2018
1	Interleukin-10 (Interleukin 10)IBA 01/2018
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2018
1	Dinoprostone (PGE2)FDA Link 01/2018
1	Phenobarbital (Luminal)FDA Link 04/2016
1	Interleukin-15 (Interleukin 15)IBA 01/2016
1	p21-Activated KinasesIBA 12/2015
1	Tamoxifen FDA LinkGeneric 12/2015
1	1- (2- (1- (2- aminopyrimidin- 4- yl)- 2- ((2- methoxyethyl)amino)- 1H- 1,3- benzodiazol- 6- yl)ethynyl)cyclohexan- 1- olIBA 12/2015
1	Vinblastine (Vinblastine Sulfate)FDA Link 01/2012
1	Methotrexate (Mexate)FDA LinkGeneric 01/2012
1	Cisplatin (Platino)FDA LinkGeneric 01/2012
1	Gemcitabine FDA Link 01/2012
1	Carboplatin (JM8)FDA LinkGeneric 01/2012

Therapy/Procedure

3	Therapeutics 01/2022 - 01/2016
2	Drug Therapy (Chemotherapy) 01/2018 - 01/2012
1	Neoadjuvant Therapy 01/2018